deltatrials
Completed PHASE3 INTERVENTIONAL 3-arm NCT04028492

Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis

VP-VLY-686-3301: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase Iii Study To Assess The Efficacy Of Tradipitant In Relieving Symptoms Of Gastroparesis

Sponsor: Vanda Pharmaceuticals

Updated 9 times since 2019 Last updated: Jul 21, 2025 Started: Aug 20, 2019 Primary completion: Feb 21, 2025 Completion: Feb 21, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04028492, this PHASE3 trial focuses on Diabetic Gastroparesis and Gastroparesis and remains completed. Sponsored by Vanda Pharmaceuticals, it has been updated 9 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Aug 2019 – ~Jan 2021 · 17 months · monthly snapshotRecruiting~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshotRecruiting~Apr 2021 – ~Apr 2023 · 24 months · monthly snapshotRecruiting~Apr 2023 – ~Oct 2023 · 6 months · monthly snapshotUnknown Status~Oct 2023 – ~Apr 2024 · 6 months · monthly snapshotRecruiting~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Aug 2025 · 11 months · monthly snapshotRecruiting~Aug 2025 – present · 11 months · monthly snapshotCompleted

Change History

9 versions recorded
  1. Aug 2025 — Present [monthly]

    Completed PHASE3

    Status: RecruitingCompleted

  2. Sep 2024 — Aug 2025 [monthly]

    Recruiting PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE3

  4. Apr 2024 — Jul 2024 [monthly]

    Recruiting PHASE3

  5. Oct 2023 — Apr 2024 [monthly]

    Recruiting PHASE3

    Status: Unknown StatusRecruiting

Show 4 earlier versions
  1. Apr 2023 — Oct 2023 [monthly]

    Unknown Status PHASE3

    Status: RecruitingUnknown Status

  2. Apr 2021 — Apr 2023 [monthly]

    Recruiting PHASE3

  3. Jan 2021 — Apr 2021 [monthly]

    Recruiting PHASE3

  4. Aug 2019 — Jan 2021 [monthly]

    Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Vanda Pharmaceuticals
Data source: Vanda Pharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .